Sign In

Remember Me

rapamycin

Anti-Aging Science: Despite Progress, Challenges Remain

Anti-Aging Science: Despite Progress, Challenges Remain

Last month a team of doctors and scientists made the case to regulators at the Food and Drug Administration (FDA) to consider approving anti-aging drugs as a new pharmaceutical class. Such a designation would treat aging as disease rather than a natural process, potentially opening the door to government funding for anti-aging drug trials. To some, such a drug may seem impossible. Yet, the physiol...

Read More »

Human genetics: One gene, twenty years

During the day, Lap-Chee Tsui and Francis Collins were attending a gene-mapping workshop. At night they were scrutinizing the pages churning out of a fax machine they had set up in a dorm room.

Read More »